Zimmer Biomet Announces First Quarter 2021 Financial Results and Full Year Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. ABBV
8. USO
9. MSFT
10. IBM

Go back to Zimmer Biomet Announces First Quarter 2021 Financial Results and Full Year Revenue Outlook

Zimmer Biomet (ZBH) PT Raised to $188 at Truist Securities Following Earnings

May 4, 2021 2:01 PM EDT

Truist Securities analyst Kaila Krum raised the price target on Zimmer Biomet (NYSE: ZBH) to $188.00 (from $174.00) while maintaining a Buy rating.

The analyst commented, "Zimmer Biomet reported 1Q21 results with both revenue and adj. EPS above consensus. After focusing on the spinoff last quarter,... More

Zimmer Biomet (ZBH) PT Raised to $202 at Needham & Company Following Earnings

May 4, 2021 2:00 PM EDT

Needham & Company analyst Mike Matson raised the price target on Zimmer Biomet (NYSE: ZBH) to $202.00 (from $192.00) while maintaining a Strong Buy rating.

The analyst commented, "ZBH's 1Q21 revenue and EPS beat consensus. ZBH's underlying revenue growth improved in 1Q21, which we believe was... More

Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 18c, Revenues Beat; Offers FY21 EPS Mid-Point Guidance Above Consensus

May 4, 2021 6:35 AM EDT

Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $1.71, $0.18 better than the analyst estimate of $1.53. Revenue for the quarter came in at $1.85 billion versus the consensus estimate of $1.76 billion.

"Our performance was stronger than we anticipated in the first quarter, as we... More